Navigation Links
New Criteria for Alzheimer's Diagnosis Proposed
Date:7/14/2010

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, July 14 (HealthDay News) -- A draft proposal that would update the diagnostic criteria for Alzheimer's disease for the first time in 25 years has just been presented to Alzheimer's experts.

The key change would put more focus on the various stages of the condition, according to the drafts from three workgroups convened by the U.S. National Institute on Aging and the Alzheimer's Association.

While these criteria are still in use, experts say the field has changed a great deal since they were created in 1984.

"These changes are inevitable, given the forward movement of the scientific knowledge regarding Alzheimer's -- how it develops, how it progresses and how it impacts the patient," said Dr. Martin Goldstein, director of the department of neurology at Mount Sinai School of Medicine in New York City.

Developing methods to identify Alzheimer's in its first stages is essential to the early diagnosis of the disease, he added. This can also lead to new treatments.

"The proposals would change the 1984 criteria by better reflecting the various stages of the disease and the inclusion of Alzheimer's disease biomarkers," William Thies, chief medical and scientific officer at the Alzheimer's Association, said in a news release from the organization.

"While the role of biomarkers differs in each of the three stages, much remains to be understood concerning their reliability and validity in diagnosis. This makes it critical that we thoroughly test any new recommendations," Thies added.

The proposed changes were presented Tuesday at the Alzheimer's Association International Conference on Alzheimer's Disease 2010, in Honolulu.

Among the reasons the criteria need to be updated is the new understanding that Alzheimer's starts years before symptoms are apparent, experts said. The earlier the disease can be identified, the better are the chances to slow its development, they added.

Among the ways researchers are identifying Alzheimer's are through genetic analysis and with biomarkers that can be seen on PET and MRI scans and in cerebrospinal fluid.

These include finding disorders in beta amyloid metabolism and the molecules tau and phospho-tau in cerebrospinal fluid.

In addition, since 1984 there has been a better understanding of the differences between Alzheimer's disease and other types of dementia.

Much more is known about dementia caused by Lewy Body disease and Pick's disease and other frontotemporal dementias.

The proposed changes in diagnosing Alzheimer's will take into account preclinical disease, which can help identify Alzheimer's before symptoms appear; mild cognitive impairment, which can be the first signs of Alzheimer's; and looking into recommending specific biomarkers, which can aid in diagnosis.

Goldstein noted that these proposed changes will lead to new problems, including who should be screened and at what cost. "These changes have significant economic service delivery implications. It has significant public health implications, but it's ultimately a worthy goal," he said.

In addition, there are no effective treatments for Alzheimer's. "Current treatments are primarily symptomatic," Goldstein said. "The ultimate goal is stopping the pathological process long before it develops a momentum that can't be stopped."

Another expert, Mony de Leon, director of the Center for Brain Health at NYU Langone Medical Center in New York City, called the proposed changes "long overdue."

The ultimate goal is to find a treatment for Alzheimer's, de Leon said. "But unless you know who needs the drug, how do you develop a drug?" he stated. "You need the early diagnosis before you can even consider the prevention work."

David Loewenstein, a professor of psychiatry and behavioral sciences at the University of Miami Miller School of Medicine, added that "a diagnosis of Alzheimer's used to be a diagnosis of exclusion."

If a patient had cognitive impairment that interfered with their social functioning, then Alzheimer's disease was the diagnosis by excluding all other causes, he explained.

"These new criteria are based on the fact that new science is showing that we actually have biomarkers that are sensitive to early Alzheimer's disease," Loewenstein said.

More information

For more information on Alzheimer's disease, visit the Alzheimer's Association.

SOURCES: Mony de Leon, Ed.D., professor, department of psychiatry, and director, Center for Brain Health, NYU Langone Medical Center, New York City; Martin Goldstein, M.D., assistant professor, and director, department of neurology, Mount Sinai School of Medicine, New York City; David Loewenstein, Ph.D., professor of psychiatry and behavioral sciences, University of Miami Miller School of Medicine; July 13, 2010, Alzheimer's Association meeting, Honolulu


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Professionals think that there arent criteria for certifying that an illness is terminal
2. New criteria proposed for diagnosing fibromyalgia
3. New CASA* Report Finds: 65 Percent of All U.S. Inmates Meet Medical Criteria for Substance Abuse Addiction, Only 11 Percent Receive Any Treatment
4. Genetic Ancestry Data Improve Diagnosis in Asthma and Lung Disease
5. Many Docs Deliver Cancer Diagnosis Badly: Study
6. Why are blacks more likely to die from cancer diagnosis?
7. AAO-HNS releases consensus statement: diagnosis and management of nasal valve compromise
8. How likely is misdiagnosis?
9. Partners grieve rheumatoid arthritis diagnosis as much as patients
10. Lung cancer research concludes that early diagnosis as key for improving survival
11. False positives in TB diagnosis lead to real negatives for HIV patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Criteria for Alzheimer's Diagnosis Proposed
(Date:7/18/2017)... ... July 19, 2017 , ... USHEALTH Group, Inc. ... Initiative in the prestigious CEO World Awards®. The coveted annual CEO World ... and services, CEO case studies, corporate social responsibility, and milestones from every major ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... Its Treatments during Pregnancy , studies take a closer look at maternal depression, ... developing baby with one study showing newer medications may be safer choices. , ...
(Date:7/17/2017)... Connecticut (PRWEB) , ... July 17, 2017 , ... McGraw ... Enhance Patient Care and Train Next Generation of Healthcare Clinicians , NORWALK, Connecticut ... McGraw-Hill, is continuing its legacy of investing in community health by pledging up to ...
(Date:7/17/2017)... ... 2017 , ... Altec Products, Inc., a leader in enterprise document ... in Atlanta, Georgia. The four-day training session, which begins today and continues through ... more efficiently and effectively. , Covering topics such as Smart Form Toolkit, Security, ...
(Date:7/17/2017)... Pomona, California (PRWEB) , ... July 17, 2017 ... ... a “Great College to Work For” by the Chronicle of Higher Education for ... consecutive year. , WesternU, which has campuses in Pomona, California and Lebanon, Oregon, ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017  Dr. Echenberg, founder of Echenberg Institute, ... program to patients who suffer from painful intercourse and other painful pelvic ... vaginal atrophy due to menopause. ... VuVatech LLC ... created by Sarasota, Florida -based start-up company, VuVatech LLC, ...
(Date:7/10/2017)... , July 10, 2017 The Institute ... test methods, is the recipient of a VITROCELL® inhalation ... PETA International Science Consortium. The device, which is designed ... to expose human lung cells to airborne test materials ... will use the VITROCELL® system for testing combustible tobacco ...
(Date:7/10/2017)... RESEARCH TRIANGLE PARK, N.C. , July 10, 2017 ... of a $5m Convertible Note to support the development ... led by Tencent Holdings Limited, a leading Chinese Internet ... Center. This funding will advance multiple infectious disease product ... Founded by Dr. ...
Breaking Medicine Technology: